Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05720845
Other study ID # 20230111
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 8, 2023
Est. completion date March 18, 2025

Study information

Verified date January 2023
Source Guangzhou Institute of Respiratory Disease
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This trial compares two different types of ventilation for the prevention of partial or complete collapsed lung (atelectasis) in patients undergoing interventional pulmonology procedures under general anesthesia. Ventilatory strategy to prevent reduce the intra-procedural development of atelectasis during interventional pulmonology procedures under general anesthesia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date March 18, 2025
Est. primary completion date January 18, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Adult patients undergoing interventional pulmonology procedures with radial probe endobronchial ultrasound (RP-EBUS) for peripheral lung lesions - Recent (< 4 weeks) chest computed tomography (CT) performed prior to the bronchoscopy Exclusion Criteria: - Patients with baseline lung consolidation, interstitial changes or lung masses (> 3 cm in diameter) in dependent areas of the lung (right/left [R/L] B6, 9, or 10 bronchial segments) as seen on most recent CT - History of primary or secondary spontaneous pneumothorax

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
VESPA
Using Ventilatory strategy of prevent atelectasis for General Anesthesia.
conventional mechanical ventilation
Conventional mechanical ventilation for General Anesthesia.

Locations

Country Name City State
China Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Guangzhou Institute of Respiratory Disease

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Presence or absence of new atelectasis for each segment The proportion of patients identified as developing intraprocedural atelectasis by radial probe endobronchial ultrasound (RP-EBUS) During bronchoscopy, an average of 1 hour.
Secondary Ventilation-induced complications Within 48 hours of bronchoscopy
Secondary Bronchoscopy-induced complications Within 48 hours of bronchoscopy
Secondary Assess the regional ventilation distribution by Electrical impedance tomography (EIT) During bronchoscopy, an average of 1 hour.
See also
  Status Clinical Trial Phase
Completed NCT00981344 - Wheeled Mobility in Everyday Life N/A
Completed NCT04311723 - Ventilatory Strategy for the Prevention of Atelectasis During Bronchoscopy Under General Anesthesia, VESPA Trial N/A
Active, not recruiting NCT02341326 - Defective FGFR2 Signaling in the Small Airway Basal Progenitor Cells in COPD
Terminated NCT02188511 - Effects of Electronic Cigarettes on Lung Biology N/A